BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4182)

  • 1. Proceedings: Two types of intrinsic sympathomimetic activity with beta-adrenoceptor blocking drugs.
    Bilski A; Wale J; Dawes PM
    Br J Pharmacol; 1976 Mar; 56(3):362P. PubMed ID: 4182
    [No Abstract]   [Full Text] [Related]  

  • 2. A test which may demonstrate in man, intrinsic sympathomimetic activity of beta-adrenoceptor blocking drugs [proceedings].
    Harry JD; Knapp MF; Linden RJ; Newcombe CP; Stoker JB
    Br J Clin Pharmacol; 1975 Aug; 2(4):374P. PubMed ID: 9951
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade.
    McDevitt DG; Brown HC; Carruthers SG; Shanks RG
    Clin Pharmacol Ther; 1977 May; 21(5):556-66. PubMed ID: 15753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute hemodynamic effects of five beta-adrenoceptor blocking agents in man: the significance of selectivity and intrinsic sympathomimetic activity.
    Lysbo Svendsen T; Trap-Jensen J; Bliddal J; Hartling O; McNair A
    Acta Med Scand Suppl; 1979; 625():26-30. PubMed ID: 34979
    [No Abstract]   [Full Text] [Related]  

  • 5. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.
    Svendsen TL
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S21-5. PubMed ID: 6188916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can ISA compensate for bradycardia due to beta-adrenoceptor blockade?
    Lohmöller G; Stocker K
    Br J Clin Pharmacol; 1982; 13(Suppl 2):315S. PubMed ID: 6125182
    [No Abstract]   [Full Text] [Related]  

  • 7. A study of the relationship between cardiac beta-adrenoceptor blockade and intrinsic sympathomimetic activity in rats depleted of catecholamines.
    Bilski A; Robertson HH; Wale JL
    Clin Exp Pharmacol Physiol; 1979; 6(1):1-9. PubMed ID: 32980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate haemodynamic effects of propranolol, practolol, pindolol, atenolol and ICI 89,406 in healthy volunteers.
    Svendsen TL; Hartling O; Trap-Jensen J
    Eur J Clin Pharmacol; 1979 May; 15(4):223-8. PubMed ID: 38968
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proceedings: Combined effects of Lb46 resp. practolol and histamine on parameters of respiration and circulation in guinea pigs.
    Kilian U; Dittmann EC
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R47. PubMed ID: 4152364
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
    Horii D; Kawada T; Takeda K; Imai S
    Arzneimittelforschung; 1974 Sep; 24(9):1275-7. PubMed ID: 4154764
    [No Abstract]   [Full Text] [Related]  

  • 12. Electrophysiological effects of cardioselective and non-cardioselective beta-adrenoceptor blockers with and without ISA at rest and during exercise.
    Hombach V; Braun V; Höpp HW; Gil-Sanchez D; Behrenbeck DW; Tauchert M; Hilger HH
    Br J Clin Pharmacol; 1982; 13(Suppl 2):285S-293S. PubMed ID: 6125178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac and bronchial beta-adrenoceptor antagonistic potencies of atenolol, metoprolol, acebutolol, practolol, propranolol and pindolol in the anaesthetized dog.
    Harms HH; Spoelstra AJ
    Clin Exp Pharmacol Physiol; 1978; 5(1):53-9. PubMed ID: 25152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac effects of beta-adrenoceptor blockade with intrinsic sympathomimetic activity during submaximal exercise.
    Ades PA
    Br J Clin Pharmacol; 1987; 24 Suppl 1(Suppl 1):29S-33S. PubMed ID: 2894223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of metipranolol and other beta-blockers on the heart in reserpinized rats.
    Vanĕcek M; Trcka V; Helfert I
    Acta Univ Carol Med (Praha); 1980; 26(7-8):339-43. PubMed ID: 6126106
    [No Abstract]   [Full Text] [Related]  

  • 16. Isoprenaline antagonism and duration of action in exercise induced tachycardia of three -adrenoceptor blocking drugs: pindolol, LF 17-895 and propranolol.
    Aellig WH
    Br J Pharmacol; 1973 Mar; 47(3):621P-622P. PubMed ID: 4147193
    [No Abstract]   [Full Text] [Related]  

  • 17. Blockade of isoprenaline-induced changes in plasma free fatty acids, immunoreactive insulin levels and plasma renin activity in healthy human subjects, by propranolol, pindolol, practolol, atenolol, metoprolol and acebutolol.
    Harms HH; Gooren L; Spoelstra AJ; Hesse C; Verschoor L
    Br J Clin Pharmacol; 1978 Jan; 5(1):19-26. PubMed ID: 23133
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiac beta-adrenoceptor blockade: the quest for selectivity.
    Barrett AM
    J Pharmacol; 1985; 16 Suppl 2():95-108. PubMed ID: 2867254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Editorial: Importance of cardioselectivity and sympaticomimetric potential of beta-blockers (author's transl)].
    Dubach UC
    Schweiz Rundsch Med Prax; 1975 Sep; 64(39):1239-41. PubMed ID: 241073
    [No Abstract]   [Full Text] [Related]  

  • 20. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
    Antonaccio MJ; High J; DeForrest JM; Sybertz E
    J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.